DERMOCUAD

This brand name is authorized in Ecuador

Active ingredients

The drug DERMOCUAD contains a combination of these active pharmaceutical ingredients (APIs):

1 Tolnaftate
UNII 06KB629TKV - TOLNAFTATE
Read about Tolnaftate
2 Clioquinol
UNII 7BHQ856EJ5 - CLIOQUINOL
Read about Clioquinol
3 Betamethasone
UNII 9IFA5XM7R2 - BETAMETHASONE VALERATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Read about Betamethasone
4 Gentamicin
UNII 8X7386QRLV - GENTAMICIN SULFATE

Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits.

Read about Gentamicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D07CC Corticosteroids, potent, combinations with antibiotics D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics
Discover more medicines within D07CC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 29524-12-10

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.